ReviewMolecules (Basel, Switzerland)2021

What Is the Mechanism Driving the Reduction of Cardiovascular Events from Glucagon-like Peptide-1 Receptor Agonists?-A Mini Review.

Jared Berndt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.